VRDN Latest Press Releases

-- March 31, 2026 --

Viridian Therapeutics, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses Globe Newswire 11:00 AM

-- March 30, 2026 --

Viridian Therapeutics Announces Positive Topline Results from Elegrobart Phase 3 REVEAL-1 Clinical Trial in Active Thyroid Eye Disease Business Wire 7:03 AM

-- February 26, 2026 --

Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2025 Financial Results Business Wire 7:01 AM

-- January 8, 2026 --

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:01 PM

-- January 6, 2026 --

Viridian Therapeutics Prepares for Transformational 2026 Business Wire 7:01 AM

-- December 22, 2025 --

Viridian Therapeutics Announces BLA Acceptance and Priority Review for Veligrotug for the Treatment of Thyroid Eye Disease Business Wire 7:00 AM

-- December 5, 2025 --

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software